https://www.prnewswire.com/news-releases/fapon-biopharma-announces-fda-approval-of-ind-for-fp008-a-first-in-class-immunotherapy-for-solid-tumors-302388341.html
Fapon Biopharma Announces FDA Approval of IND for FP008, a First-in-Class Immunotherapy for Solid...
/PRNewswire/ -- Fapon Biopharma, a biotech innovator in developing therapeutic antibodies and fusion proteins, is pleased to announce that the U.S. Food and...